Cannabis shares pull back in Q2 as U.S. regulatory momentum fizzles

The Botanicals Podcast

Jul 21 2021 | 00:20:20

00:00 / 00:20:20

Show Notes

Nasdaq IR Intelligence analyst Saleem Daya explains why the sector's heated year-end performance has cooled; cites rising yields, retail investor fatigue as action on U.S federal legislation remains stalled.

Other Episodes

Episode 18

December 17, 2021 • 00:13:40

Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance...

Episode 0

December 11, 2020 • 00:25:41

Hemp: 'An Economic Experiment on a Grand Scale'

JLN Editor Thom Thompson explains the twists and turns of the 2020 hemp market and looks ahead to 2021.

Episode 0

August 31, 2020 • 00:13:43

Chicago NORML: Social Equity Licenses Just the Start

Stephen Simpson, executive secretary of the cannabis advocacy group Chicago NORML, spoke with John Lothian News about the group's social equity agenda and why...